Dynamic contrast-enhanced and T2-weighted magnetic resonance imaging study of the correlation between tumour angiogenesis and growth kinetics

Laboratory Animals

Volumn 43, Issue 1, 2009, Pages 53-59

  Sathy, B N ^a   Chou, Y H ^a   Li, H J ^b   Chang, C ^a   Chow, K P N ^b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; DCE MRI; Ktrans; Tumour growth; Vascular permeability

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CARCINOGENESIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; KINETICS; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CARCINOMA; DISEASE MODELS, ANIMAL; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

HUMAN HERPESVIRUS 4;

EID: 58349099651     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2007.007105     Document Type: Article

References (33)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57
2. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003;3:643-51
3. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401-10
4. Ross BD, Chenevert TL, Rehemtulla A. Magnetic resonance imaging in cancer research. Eur J Cancer 2002;38:2147-56
5. Marzola P, Sbarbati A. Magnetic resonance imaging in animal models of pathologies. Methods Enzymol 2004;386:177-200
6. Knopp MV, Giesel FL, Marcos H, et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imaging 2001;12:301-8
7. Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001;56:607-20
8. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999;10:903-7
9. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003;17:509-20
10. Parker GJ, Tofts PS. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. Top Magn Reson Imaging 1999;10:130-42
11. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-67
12. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32
13. Li HP, Chang YS. Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 2003;10:490-504
14. Pathmanathan R, Prasad U, Sadler R, et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-8
15. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-41
16. Kulwichit W, Edwards RH, Davenport EM, et al. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci USA 1998;95:11963-8
17. Chen ML, Tsai CN, Liang CL, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992;7:2131-40
18. Steel GG. Growth Kinetics of Tumors: Cell Population Kinetics in Relation to the Growth and Treatment of Cancer. 1st edn. Oxford: Clarendon Press, 1977
19. Jackson A. Quantitative characterization of tumor microvasculature using dynamic contrast-enhanced MRI. Medicamundi 2003;47:40-7
20. Berger M, Bergers G, Arnold B, et al. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 2005;105:1094-101
21. Ryschich E, Schmidt J, Hammerling GJ, et al. Transformation of the microvascular system during multistage tumorigenesis. Int J Cancer 2002;97:719-25
22. Knighton D, Ausprunk D, Tapper D, et al. Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 1977;35:347-56
23. Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61
24. Hicks RM, Chowaniec J. Experimental induction, histology, and ultrastructure of hyperplasia and neoplasia of the urinary bladder epithelium. Int Rev Exp Pathol 1978;18:199-280
25. Sillman F, Boyce J, Fruchter R. The significance of atypical vessels and neovascularization in cervical neoplasia. Am J Obstet Gynecol 1981;139:154-9
26. Smith-McCune KK, Weidner N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994;54:800-4
27. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-8
28. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-8
29. Kim ES, Serur A, Huang J, et al. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proc Natl Acad Sci USA 2002;99:11399-404
30. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology 2004;19:176-82
31. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-lalpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998;394:485-90
32. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 2000;14:34-44
33. Ross BD, Moffat BA, Lawrence TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2003;2:581-7